A Pilot Double-Blind, Parallel Group, Placebo Controlled Study of Oxaloacetate in Subjects With Treated Parkinson's Disease
Parkinson's Disease
Enrolment: 33 · Results not recorded
Loading the evidence…
Drug
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Parkinson's Disease
Enrolment: 33 · Results not recorded
Early-Stage Breast Carcinoma
Enrolment: 18 · Results not recorded
ALS
Enrolment: 18 · Results not recorded
Alzheimer's Disease
Enrolment: 32 · Results not recorded
Myasthenia Gravis
Enrolment: 0 · Results not recorded
Alzheimer's Disease
Enrolment: 6 · Results not recorded
Myalgic Encephalomyelitis · Chronic Fatigue Syndrome · Fatigue
Enrolment: 82 · Results not recorded
Post-COVID-19 Syndrome · Fatigue Syndrome, Chronic
Enrolment: 70 · Results not recorded
Premenstrual Syndrome
Enrolment: 48 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Mouse models of moderate and severe traumatic brain injury with secondary traumatic brain injury-induced acute lung injury
Raising blood glutamate worsened lung water content, lung-body index, bronchoalveolar inflammatory markers, lung injury score, incidence of acute lung injury and mortality, and lowered PaO2/FiO2, with further worsening when an A2AR activator was co-administered. Lowering blood glutamate by peritone…
Extraction: extract · Supplied extraction confidence: 0.65. Machine-extracted fields require source verification.